This past June Vancouver’s Heart Force Medical Inc. was awarded the Most Promising Pre-commercial Technology Award by the British Columbia Technology Industry Association at its 2009 Technology Impact Awards.
Heart Force’s award-winning technology is the digital Ballistocardiograph (dBG) – a non-invasive medical device that assesses cardiac function by sensing forces generated from heart muscle contractions, relaying results via Bluetooth technology.
While the dBG had already been approved in Canada at the time of the BCTIA award, it was still in the final stage of certification in the FDA approval process for use in the United States.
Well, earlier this month, Heart Force received USFDA 510(k) clearance of its dBG 300 Digital Ballistocardiograph – a huge step for a little company from Vancouver.
“This further confirms the value of the dBG. We already have Health Canada approval. Receiving certification from the USFDA, which is accepted as the International Standard for regulatory compliance, gives us unfettered access to the US Market. This allows us to fully define how our product will be best used to assist physicians in their assessment of patients’ cardiac performance”, said Dr. Geoff Houlton, Heart Force Medical’s President and CEO. “We are currently evaluating a number of business options that will enable HFM to generate revenues for the dBG 300 as quickly as possible.”
Heart Force Medical is based in Vancouver and privately-held – for now.